https://www.selleckchem.com/pr....oducts/ferrostatin-1
The risk of development of new sensitization was higher in the non-SCIT group than in the SCIT group (relative risk 1.92 [95% confidence interval CI, 1.30-2.85]; p less then 0.05). The eosinophil count of the participants significantly differed in the complete response (CR) group (p less then 0.05) but not in the non-CR group (p = 0.098). However, the serum total immunoglobulin E value was not significantly reduced (p = 0.204). Of 8421 injections given to the patients, 231 injections (2.74%) showed adverse effects during the treat
Like
Comment
Share
